| First Author | Parajuli P | Year | 2019 |
| Journal | EMBO J | Volume | 38 |
| Issue | 13 | Pages | e101067 |
| PubMed ID | 31268604 | Mgi Jnum | J:387156 |
| Mgi Id | MGI:6323335 | Doi | 10.15252/embj.2018101067 |
| Citation | Parajuli P, et al. (2019) TGIF1 functions as a tumor suppressor in pancreatic ductal adenocarcinoma. EMBO J 38(13):e101067 |
| abstractText | A prominent function of TGIF1 is suppression of transforming growth factor beta (TGF-beta) signaling, whose inactivation is deemed instrumental to the progression of pancreatic ductal adenocarcinoma (PDAC), as exemplified by the frequent loss of the tumor suppressor gene SMAD4 in this malignancy. Surprisingly, we found that genetic inactivation of Tgif1 in the context of oncogenic Kras, Kras(G12D) , culminated in the development of highly aggressive and metastatic PDAC despite de-repressing TGF-beta signaling. Mechanistic experiments show that TGIF1 associates with Twist1 and inhibits Twist1 expression and activity, and this function is suppressed in the vast majority of human PDACs by Kras(G12D) /MAPK-mediated TGIF1 phosphorylation. Ablating Twist1 in Kras(G12D) ;Tgif1(KO) mice completely blunted PDAC formation, providing the proof-of-principle that TGIF1 restrains Kras(G12D) -driven PDAC through its ability to antagonize Twist1. Collectively, these findings pinpoint TGIF1 as a potential tumor suppressor in PDAC and further suggest that sustained activation of TGF-beta signaling might act to accelerate PDAC progression rather than to suppress its initiation. |
